Bart G.J. Knols's blog
Mass Drug Administration (MDA) is a tantalizing tool that can support elimination efforts and help dramatically knock down malaria prevalence. Why isn’t it more widely used?
by George Jagoe
It is with great sadness that I report the passing of my friend, colleague and my former PhD student Dr. Ernst-Jan Scholte, yesterday, 16 March 2014. Although obituaries are normally written for scientists that died at an old age and had a massive track record in our field, I feel the urge to commemorate and remember this great person in front of you all at MalariaWorld. He became only 40 years of age - after fighting cancer for a year.
Ernst-Jan first contacted me in 1998 when he was still a biology student at the Wageningen University. At that time I was working in Nairobi for the International Centre of Insect Physiology and Ecology (ICIPE). Ernst-Jan (or EJ as many called him) wanted to study mosquitoes and do an internship with me for six months. He was lucky. Within a week after he arrived in Kenya we undertook a wonderful safari to the border with Tanzania, visiting and hiking in a Masai area where I had previously worked on tsetse flies. EJ loved it from day one. He fell in love with Africa, its people and its wildlife, and was extremely motivated in his work. I will never forget the nights we camped out in the bush together...
The freely available book titled "Artemisia annua,Artemisinin, ACTs & Malaria Control in Africa: Tradition, Science and Public Policy", has been updated by the author, Dana Dalrymple, and has been expanded with an Annex (Annex 7), titled: "The Early Role of Novartis in ACT Development" (pp. 189-192).
The book is attached to this blog. We are grateful to Dr. Dalrymple to make this updated version available for free to MalariaWorld subscribers.
The MW team.